INDOCO REMEDIES
|
INDOCO REMEDIES Last 5 Year Balance Sheet History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
EQUITY AND LIABILITIES | |||||
Share Capital | ₹18 Cr | ₹18 Cr | ₹18 Cr | ₹18 Cr | ₹18 Cr |
Equity - Authorised | ₹25 Cr | ₹25 Cr | ₹25 Cr | ₹25 Cr | ₹25 Cr |
Equity - Issued | ₹18 Cr | ₹18 Cr | ₹18 Cr | ₹18 Cr | ₹18 Cr |
Equity Paid Up | ₹18 Cr | ₹18 Cr | ₹18 Cr | ₹18 Cr | ₹18 Cr |
Equity Shares Forfeited | - | - | - | - | - |
Adjustments to Equity | - | - | - | - | - |
Preference Capital Paid Up | - | - | - | - | - |
Face Value | ₹2.00 | ₹2.00 | ₹2.00 | ₹2.00 | ₹2.00 |
Share Warrants & Outstandings | ₹0.66 Cr | - | - | - | - |
Total Reserves | ₹1,009 Cr | ₹886 Cr | ₹751 Cr | ₹661 Cr | ₹642 Cr |
Securities Premium | ₹64 Cr | ₹64 Cr | ₹64 Cr | ₹64 Cr | ₹64 Cr |
Capital Reserves | - | - | - | - | - |
Profit & Loss Account Balance | ₹687 Cr | ₹564 Cr | ₹428 Cr | ₹339 Cr | ₹320 Cr |
General Reserves | ₹258 Cr | ₹258 Cr | ₹258 Cr | ₹258 Cr | ₹258 Cr |
Other Reserves | - | - | - | - | - |
Reserve excluding Revaluation Reserve | ₹1,009 Cr | ₹886 Cr | ₹751 Cr | ₹661 Cr | ₹642 Cr |
Revaluation reserve | - | - | - | - | - |
Shareholder's Funds | ₹1,028 Cr | ₹905 Cr | ₹769 Cr | ₹680 Cr | ₹661 Cr |
Minority Interest | - | - | - | - | - |
Long-Term Borrowings | - | - | - | - | - |
Secured Loans | ₹144 Cr | ₹96 Cr | ₹97 Cr | ₹97 Cr | ₹129 Cr |
Non Convertible Debentures | - | - | - | - | - |
Converible Debentures & Bonds | - | - | - | - | - |
Packing Credit - Bank | - | - | - | - | - |
Inter Corporate & Security Deposit | - | - | - | - | - |
Term Loans - Banks | ₹190 Cr | ₹129 Cr | ₹110 Cr | ₹92 Cr | ₹95 Cr |
Term Loans - Institutions | - | - | - | - | - |
Other Secured | ₹-47 Cr | ₹-34 Cr | ₹-13 Cr | ₹4.87 Cr | ₹33 Cr |
Unsecured Loans | - | - | - | - | - |
Fixed Deposits - Public | - | - | - | - | - |
Loans and advances from subsidiaries | - | - | - | - | - |
Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
Foreign Currency Convertible Notes | - | - | - | - | - |
Long Term Loan in Foreign Currency | - | - | - | - | - |
Loans - Banks | - | - | - | - | - |
Loans - Govt. | - | - | - | - | - |
Loans - Others | - | - | - | - | - |
Other Unsecured Loan | - | - | - | - | - |
Deferred Tax Assets / Liabilities | ₹6.14 Cr | ₹11 Cr | ₹-19 Cr | ₹-36 Cr | ₹-36 Cr |
Deferred Tax Assets | ₹26 Cr | ₹30 Cr | ₹62 Cr | ₹78 Cr | ₹73 Cr |
Deferred Tax Liability | ₹32 Cr | ₹40 Cr | ₹42 Cr | ₹42 Cr | ₹37 Cr |
Other Long Term Liabilities | ₹22 Cr | ₹18 Cr | ₹14 Cr | ₹13 Cr | ₹7.32 Cr |
Long Term Trade Payables | - | - | - | - | - |
Long Term Provisions | ₹89 Cr | ₹32 Cr | ₹66 Cr | ₹27 Cr | ₹16 Cr |
Total Non-Current Liabilities | ₹261 Cr | ₹157 Cr | ₹158 Cr | ₹101 Cr | ₹116 Cr |
Current Liabilities | - | - | - | - | - |
Trade Payables | ₹123 Cr | ₹133 Cr | ₹113 Cr | ₹166 Cr | ₹171 Cr |
Sundry Creditors | ₹123 Cr | ₹133 Cr | ₹113 Cr | ₹166 Cr | ₹171 Cr |
Acceptances | - | - | - | - | - |
Due to Subsidiaries- Trade Payables | - | - | - | - | - |
Other Current Liabilities | ₹132 Cr | ₹140 Cr | ₹129 Cr | ₹136 Cr | ₹117 Cr |
Bank Overdraft / Short term credit | - | - | - | - | - |
Advances received from customers | ₹13 Cr | ₹3.72 Cr | ₹3.05 Cr | ₹6.43 Cr | ₹0.04 Cr |
Interest Accrued But Not Due | - | - | - | ₹1.10 Cr | ₹1.19 Cr |
Share Application Money | - | - | - | - | - |
Current maturity of Debentures & Bonds | - | - | - | - | - |
Current maturity - Others | - | - | - | - | - |
Other Liabilities | ₹119 Cr | ₹136 Cr | ₹126 Cr | ₹128 Cr | ₹116 Cr |
Short Term Borrowings | ₹119 Cr | ₹104 Cr | ₹117 Cr | ₹106 Cr | ₹113 Cr |
Secured ST Loans repayable on Demands | ₹19 Cr | ₹36 Cr | ₹33 Cr | ₹37 Cr | ₹40 Cr |
Working Capital Loans- Sec | ₹18 Cr | ₹34 Cr | ₹32 Cr | ₹36 Cr | ₹40 Cr |
Buyers Credits - Unsec | - | - | - | - | - |
Commercial Borrowings- Unsec | - | - | - | - | - |
Other Unsecured Loans | ₹82 Cr | ₹34 Cr | ₹53 Cr | ₹33 Cr | ₹34 Cr |
Short Term Provisions | ₹50 Cr | ₹142 Cr | ₹47 Cr | ₹52 Cr | ₹44 Cr |
Proposed Equity Dividend | - | - | - | - | - |
Provision for Corporate Dividend Tax | - | - | - | - | - |
Provision for Tax | - | ₹94 Cr | - | - | - |
Provision for post retirement benefits | ₹9.42 Cr | ₹9.35 Cr | ₹10 Cr | ₹11 Cr | ₹10 Cr |
Preference Dividend | - | - | - | - | - |
Other Provisions | ₹40 Cr | ₹38 Cr | ₹37 Cr | ₹41 Cr | ₹34 Cr |
Total Current Liabilities | ₹425 Cr | ₹518 Cr | ₹407 Cr | ₹459 Cr | ₹446 Cr |
Total Liabilities | ₹1,714 Cr | ₹1,579 Cr | ₹1,334 Cr | ₹1,240 Cr | ₹1,223 Cr |
ASSETS | |||||
Gross Block | ₹1,423 Cr | ₹1,236 Cr | ₹1,178 Cr | ₹1,127 Cr | ₹935 Cr |
Less: Accumulated Depreciation | ₹745 Cr | ₹681 Cr | ₹608 Cr | ₹537 Cr | ₹467 Cr |
Less: Impairment of Assets | - | - | - | - | - |
Net Block | ₹678 Cr | ₹555 Cr | ₹570 Cr | ₹590 Cr | ₹468 Cr |
Lease Adjustment A/c | - | - | - | - | - |
Capital Work in Progress | ₹55 Cr | ₹53 Cr | ₹25 Cr | ₹7.33 Cr | ₹141 Cr |
Non Current Investments | ₹1.46 Cr | ₹0.02 Cr | ₹0.02 Cr | ₹0.02 Cr | ₹0.02 Cr |
Long Term Investment | ₹1.46 Cr | ₹0.02 Cr | ₹0.02 Cr | ₹0.02 Cr | ₹0.02 Cr |
Quoted | - | - | - | - | - |
Unquoted | ₹1.46 Cr | ₹0.02 Cr | ₹0.02 Cr | ₹0.02 Cr | ₹0.02 Cr |
Long Term Loans & Advances | ₹108 Cr | ₹26 Cr | ₹64 Cr | ₹26 Cr | ₹22 Cr |
Other Non Current Assets | ₹4.57 Cr | ₹9.83 Cr | ₹9.59 Cr | ₹9.83 Cr | ₹9.38 Cr |
Total Non-Current Assets | ₹906 Cr | ₹712 Cr | ₹712 Cr | ₹676 Cr | ₹684 Cr |
Current Assets Loans & Advances | - | - | - | - | - |
Currents Investments | ₹1.00 Cr | - | - | - | - |
Quoted | ₹1.00 Cr | - | - | - | - |
Unquoted | ₹4.63 Cr | ₹4.63 Cr | ₹4.63 Cr | ₹4.63 Cr | ₹4.63 Cr |
Inventories | ₹326 Cr | ₹311 Cr | ₹238 Cr | ₹208 Cr | ₹183 Cr |
Raw Materials | ₹200 Cr | ₹186 Cr | ₹137 Cr | ₹119 Cr | ₹103 Cr |
Work-in Progress | ₹57 Cr | ₹43 Cr | ₹39 Cr | ₹26 Cr | ₹25 Cr |
Finished Goods | ₹34 Cr | ₹55 Cr | ₹44 Cr | ₹45 Cr | ₹37 Cr |
Packing Materials | - | - | - | - | - |
Stores Ā and Spare | ₹12 Cr | ₹4.90 Cr | ₹7.64 Cr | ₹7.53 Cr | ₹7.55 Cr |
Other Inventory | ₹21 Cr | ₹22 Cr | ₹10 Cr | ₹10 Cr | ₹11 Cr |
Sundry Debtors | ₹351 Cr | ₹297 Cr | ₹234 Cr | ₹210 Cr | ₹196 Cr |
Debtors more than Six months | ₹61 Cr | ₹52 Cr | ₹63 Cr | ₹65 Cr | ₹64 Cr |
Debtors Others | ₹322 Cr | ₹262 Cr | ₹174 Cr | ₹152 Cr | ₹142 Cr |
Cash and Bank | ₹13 Cr | ₹20 Cr | ₹14 Cr | ₹38 Cr | ₹36 Cr |
Cash in hand | ₹0.14 Cr | ₹0.11 Cr | ₹0.07 Cr | ₹0.11 Cr | ₹0.09 Cr |
Balances at Bank | ₹13 Cr | ₹20 Cr | ₹14 Cr | ₹38 Cr | ₹36 Cr |
Other cash and bank balances | - | - | - | - | - |
Other Current Assets | ₹20 Cr | ₹35 Cr | ₹12 Cr | ₹9.11 Cr | ₹16 Cr |
Interest accrued on Investments | - | - | - | - | - |
Interest accrued on Debentures | - | - | - | - | - |
Deposits with Government | - | - | - | - | - |
Interest accrued and or due on loans | - | - | - | - | - |
Prepaid Expenses | ₹12 Cr | ₹9.54 Cr | ₹8.63 Cr | ₹5.37 Cr | ₹5.35 Cr |
Other current_assets | ₹8.62 Cr | ₹25 Cr | ₹3.27 Cr | ₹3.75 Cr | ₹10 Cr |
Short Term Loans and Advances | ₹97 Cr | ₹205 Cr | ₹125 Cr | ₹98 Cr | ₹107 Cr |
Advances recoverable in cash or in kind | ₹22 Cr | ₹13 Cr | ₹24 Cr | ₹12 Cr | ₹11 Cr |
Advance income tax and TDS | - | ₹93 Cr | - | - | - |
Amounts due from directors | - | - | - | - | - |
Due From Subsidiaries | - | - | - | - | - |
Inter corporate deposits | - | - | - | - | - |
Corporate Deposits | - | - | - | - | - |
Other Loans & Advances | ₹75 Cr | ₹98 Cr | ₹101 Cr | ₹85 Cr | ₹96 Cr |
Total Current Assets | ₹808 Cr | ₹867 Cr | ₹623 Cr | ₹563 Cr | ₹538 Cr |
Net Current Assets (Including Current Investments) | ₹384 Cr | ₹349 Cr | ₹216 Cr | ₹104 Cr | ₹93 Cr |
Miscellaneous Expenses not written off | - | - | - | - | - |
Total Assets | ₹1,714 Cr | ₹1,579 Cr | ₹1,334 Cr | ₹1,240 Cr | ₹1,223 Cr |
Contingent Liabilities | ₹83 Cr | ₹60 Cr | ₹56 Cr | ₹52 Cr | ₹25 Cr |
Total Debt | ₹315 Cr | ₹244 Cr | ₹259 Cr | ₹262 Cr | ₹296 Cr |
Book Value | 111.51 | 98.17 | 83.45 | 73.75 | 71.69 |
Adjusted Book Value | 111.51 | 98.17 | 83.45 | 73.75 | 71.69 |
Compare Balance Sheet of peers of INDOCO REMEDIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
INDOCO REMEDIES | ₹3,028.8 Cr | -0.1% | -11.7% | 1.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹388,812.0 Cr | 3% | 2.3% | 68.2% | Stock Analytics | |
CIPLA | ₹120,673.0 Cr | 2.5% | 0.4% | 71.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹102,679.0 Cr | -0.2% | -4.9% | 40.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹101,152.0 Cr | 5% | 10.4% | 109.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹91,234.9 Cr | -1.6% | -7% | 23.8% | Stock Analytics |
INDOCO REMEDIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
INDOCO REMEDIES | -0.1% |
-11.7% |
1.9% |
SENSEX | -0.4% |
-0.9% |
25.8% |
You may also like the below Video Courses